Based on the limited number of cancer studies on TLR1 and TLR2, it appears that their modulation is cancer-type dependent, with a pro-tumoral role in CRC, gastric and ovarian tumors and an anti-tumoral role in melanoma and lung cancer. This evidence concerns the gene TLR2 and cancer.